CAS: 17680-04-5; Magnesium,5H-1,3-Benzodioxol-5-Ide,Bromide

该化合物是有机合成中常用的一种灰色试剂,用于引入3,4-亚甲基二氧基苯基功能组,该化合物在形成碳碳-碳债券方面特别宝贵,能够合成复杂的芳香和热循环结构,其高度的回动性和选择性使它成为碳基化合物的核生殖性添加以及混合反应的首选选择.该试剂通常作为一种溶液在高氢或二乙基醚中供应,确保处理的稳定性和方便性.在惰性条件下适当储存对于保持其再活动至关重要,其应用范围包括药物,农用化学和材料科学,其中精确的功能化至关重要.

结构式图片

欧盟法规

C&L通报

上下游产品

1,2-(methylenedioxy)-4-bromobenzene magnesium -4-cyclohexenecarboxylic acid(1R*,2S*)-2-3',4'-(methylenedioxy)benzoyl-4-cyclohexenecarboxylic acid (-)-asarinin trans-4-[(1,3-benzodioxol-5-yl)hydroxymethyl]-3-[(1,3-mbenzodioxol-5-yl)methyl]dihydro-2(3H)-furanone -1,3-dioxolan-5-yl)-(3S,2R)-3--2,2-dimethyl(1,3-dioxolan-4-yl)>-2,3-bis(methoxymethyl)propan-1-ol1-(2H-benzo3,4-d-1,3-dioxolan-5-yl)-(3S,2R)-3-(5S,4R)-5-(1Z)-2-aza-2-(phenylmethoxy)vinyl-2,2-dimethyl(1,3-dioxolan-4-yl)-2,3-bis(methoxymethyl)propan-1-ol

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6172235-B1
    优先权日:1996-08-09
    标题 :Asymmetric conjugate addition reaction
    发明人:DOLLING ULF H; FREY LISA F; TILLYER RICHARD D; TSCHAEN DAVID M
    权利人:MERCK & CO INC
    摘要:This invention relates to a key intermediate in the synthesis of an endothelin antagonist and the synthesis of this key intermediate using an asymmetric conjugate addition reaction.

    专利号:US-2015038591-A1
    优先权日:2002-05-31
    标 题:Compounds, compositions and methods for the treatment of tauopathies
    发明人:SNOW ALAN D; CAM JUDY A; CASTILLO GERARDO; HU QUBAI; LAKE THOMAS
    权利人:PROTEOTECH INC
    摘要:Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of tauopathies, such as Alzheimer's disease and Parkinson's disease, and the manufacture of medicaments for such treatment.

    专利号:US-7919530-B2
    优先权日:2002-05-31
    标 题 :Compounds, compositions, and methods for the treatment of synucleinopathies
    发明人:ESPOSITO LUKE A; CUMMINGS JOEL; HUDSON F MICHAEL; SNOW ALAN D
    权利人:PROTEOTECH INC
    摘要:Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.

    专利号:US-7601876-B2
    优先权日:2002-05-31
    标题 :Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
    发明人:SNOW ALAN D; NGUYEN BETH P; CASTILLO GERARDO M; SANDERS VIRGINIA J; LAKE THOMAS P; LARSEN LESLEY; WEAVERS REX T; LORIMER STEPHEN D; LARSEN DAVID S; COFFEN DAVID L; COFFEN CHARLOTTE
    权利人:PROTEOTECH INC
    摘要:Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, AA/SAA amyloidosis, such as observed in systemic AA amyloidosis and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Gagnon, A.; Benoit, E.; Le Roch, A., Science of Synthesis Knowledge Updates, (2018) 4, 2.
    摘要:Aitken, R. A., Science of Synthesis Knowledge Updates, (2022) 2, 3.
    摘要:Lu, J.-M.; Shao, L.-X., Science of Synthesis Knowledge Updates, (2020) 3, 362.
    摘要:Adak, L.; Sahoo, S.; Aoki, S.; Kawanaka, Y.; Nakamura, M., Science of Synthesis: Base-Metal Catalysis, (2023) 2, 391.
    摘要:Zeng, X., Science of Synthesis: Base-Metal Catalysis, (2023) 2, 765.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知